Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA and Pregnenolone for Tobacco Withdrawal in Male Smokers
NCT00900900Phase 2Completed
- Start
- Jul 2009
- Primary completion
- Mar 2011
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of dehydroepiandrosterone, pregnenolone in Tobacco Withdrawal. Started Jul 2009; status: completed.
02
Drugs
dehydroepiandrosteronepregnenolone
03
Conditions
Tobacco Withdrawal
Beyond the preview
Go deeper on NCT00900900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00900900.